Predictive Factors for Term Infants with Neonatal Hyperbilirubinemia Requiring Readmission for Phototherapy

  • Sariya Prachukthum Faculty of Medicine, Thammasat University
  • Chamnan Tanprasertkul Faculty of Medicine, Thammasat University
  • Sukkrawan Intarakhao Faculty of Medicine, Thammasat University
Keywords: Jaundice, Neonatal hyperbilirubinemia, Predict, Readmission, Term infant

Abstract

Background: Neonatal jaundice is one of the most common problems which often develops after term infants are discharged at the age of 48 hours. Identifying risk factors may prevent severe hyperbilirubinemia which can cause an irreversible neuronal damage.


Objectives: To predict which term infants would need phototherapy after 48 hours of age.


Methods: A prospective cohort study of 2,841 healthy newborns with gestational age of 37 weeks or more, born at Thammasat University Hospital between June 1st, 2017 and April 19th, 2018 was conducted. Risk factors and serum bilirubin level at 48 hours of life were obtained from individual chart review. We used multivariate logistic regression to identify risk factors, and receiver operator characteristic curve (ROC curve) to compare predictive accuracy.


Results: There were 115 (3.8%) term infants with neonatal hyperbilirubinemia requiring readmission for phototherapy after 48 hours of age. Significant risk factors were predischarge bilirubin in high intermediate risk zone (adjusted odds ratio [aOR] 80.36, 95% confidence interval [CI] 37.47 - 172.36, P < 0.01), predischarge bilirubin in low intermediate risk zone (aOR 9.71, 95% CI 4.91 - 19.21, P < 0.01), gestational infants at 37-38 weeks (aOR 4.26, 95% CI 2.7 - 6.71, P < 0.01), cesarean section (aOR 2.44, 95% CI 1.6 - 3.73, P < 0.01), and weight loss more than 5% two days after birth (aOR 1.76, 95% CI 1.09 - 2.86, P = 0.02). The predictive performance of these risk factors in combination (AUC = 0.859, 95% CI = 0.82 - 0.89) was significantly different from the predictive accuracy of the predischarge bilirubin risk zone (AUC = 0.793, 95% CI = 0.76 - 0.83).


Conclusions: Predicting neonatal hyperbilirubinemia requiring readmission for phototherapy is important. The predischarge bilirubin risk level, combined with the clinical risk factors (gestational age, delivery mode, and bodyweight percentage lost at 2 days of age), was more prediction accuracy than using predischarge bilirubin risk level or either clinical risk factors.

Downloads

Download data is not yet available.

References

1. Keren R, Tremont K, Luan X, Cnaan A. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:317-322.
2. Maisels MJ, Kring E. Length of stay, jaundice and hospital readmission. Pediatrics. 1998;101:995-998.
3. Maisels MJ. Jaundice. In: Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology: Pathophysiology and Management of the Newborn. Philadelphia, PA: JB Lippincott, Co; 1999:765-819.
4. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics.
2004;114:297-316.
5. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs.
2006; 35:444-455.
6. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A Comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia
in term and near-term infants. Pediatrics. 2008;121:170-179.
7. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90:415-421.
8. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med.
2005;159:113-119.
9. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31-39.
10. Chou SC, Palmer RH, Ezhuthachan S, et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics. 2003;112:1264-1273.
11. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004;113:775-780.
12. Seidman DS, Ergaz Z, Paz I, et al. Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based study. J Perinatol. 1999;19:564-567.
13. Tarcan A, Tiker F, Vatandas NS, Haberal A, Gurakan B: Weight loss and hypernatremia in breast-fed babies: frequency in neonates with non-hemolytic jaundice. J Paediatr Child Health. 2005;41:484-487.
14. Salas AA, Salazar J, Burgoa VC, De-Villegas AC. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatrics. 2009;9:82.
15. Yang WC, Zhao LL, Li YC, et al. Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatrics. 2013;13:145.
16. Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of
subsequent hyperbilirubinemia. J Perinatol. 2009;29:612-617.
17. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med.
2005;159:113-119.
Published
2021-04-27
Section
Original Articles